Lothar Seefried

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Cell type-selective secretome profiling in vivo

Comparative analysis of differentially secreted proteins in serum-free and serum-containing media by using BONCAT and pulsed SILAC

Mechanical regulation of signaling pathways in bone

Activation of β-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE2: Implications for the study of mechanosensation in bone

3D bioactive composite scaffolds for bone tissue engineering

Therapeutic potential of adult bone marrow‐derived mesenchymal stem cells in diseases of the skeleton

Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis

Recent advances in bone tissue engineering scaffolds

Bone composition: relationship to bone fragility and antiosteoporotic drug effects

FGF-23 and secondary hyperparathyroidism in chronic kidney disease

Chronic Kidney Disease

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions

The amazing osteocyte

Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation

Estrogen receptor and Wnt signaling interact to regulate early gene expression in response to mechanical strain in osteoblastic cells

FGF23 is a putative marker for bone healing and regeneration

The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors

BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial